373231005: Musculoskeletal system agent (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1198528012 Musculoskeletal system agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1211724014 Musculoskeletal system agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4629581000005112 middel med virkning på det muskuloskeletale system da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
middel med virkning på det muskuloskeletale system	Is a	kemisk stof specificeret iht. funktion	false	Inferred relationship	Some
middel med virkning på det muskuloskeletale system	Is a	Drug, medicament or biological substance	false	Inferred relationship	Some
middel med virkning på det muskuloskeletale system	Is a	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely theophylline 10 milligram/1 milliliter conventional release oral solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin kapsel med modificeret udløsning a 65 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin kapsel med modificeret udløsning a 130 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin kapsel med modificeret udløsning a 260 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
xanthinbronchodilatorer	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing dextromethorphan and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 600 mg med modificeret udløsning/dextromethorphan 30 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 1200 mg med modificeret udløsning/dextromethorphan 60 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing guaifenesin and hydrocodone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing codeine and guaifenesin and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin + glucose	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing codeine and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing guaifenesin and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing guaifenesin and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing guaifenesin and phenylephrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing dextromethorphan and guaifenesin and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 each conventional release chewable tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Zileuton 600 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Guaifenesin 600 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
dyphyllin 125 mg/ml injektionsvæske, opløsning, ampul a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
dyphyllin 160 mg/15 ml eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 50 mg/1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 400 mg/10 ml væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Guaifenesin 800 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 100 mg/5 ml oral væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely guaifenesin 300 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
dyphyllin 100 mg/15 ml eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Diprophylline 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Diprophylline 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Guaifenesin 1 g oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Guaifenesin 675 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Guaifenesin 575 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin vandfri 90 mg/150 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin 300 mg vandfri tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Theophylline anhydrous 100 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely theophylline anhydrous 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Theophylline anhydrous 300 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Theophylline anhydrous 400 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely theophylline anhydrous 50 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin 450 mg vandfri tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Theophylline 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin 500 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin 80 mg/15 ml eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely theophylline 75 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin kapsel med modificeret udløsning a 100 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Zafirlukast 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Montelukast sodium 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Montelukast sodium 4 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Theophylline 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Theophylline 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Theophylline anhydrous 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Theophylline anhydrous 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Theophylline 300 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
brompheniraminmaleat 2 mg + guaifenesin 200 mg + hydrocodonhydrogentartrat 5 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
dyphyllin 100 mg + guaifenesin 100 mg eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
dyphyllin 100 mg + guaifenesin 100 mg væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
dyphyllin 100 mg + guaifenesin 100 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Diprophylline 100 mg and guaifenesin 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
dyphyllin 100 mg + guaifenesin 50 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Diprophylline 200 mg and guaifenesin 100 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Diprophylline 200 mg and guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
ephedrinsulfat 6,25 mg + hydroxyzinhydrochlorid 2,5 mg + theophyllin 32,5 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 50 mg + oxtriphyllin 100 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 50 mg + oxtriphyllin 100 mg eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 100 mg + theophyllin 150 mg væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 100 mg + theophyllin 80 mg væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 200 mg + theophyllin 150 mg opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 90 mg + theophyllin 150 mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely guaifenesin 91.44 milligram and theophylline 152.4 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 100 mg + theophyllinnatriumglycinat 300 mg eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 90 mg+ theophyllin, vandfri 150 mg væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
kaliumjodid 130 mg + teofyllin 80 mg vandfri eliksir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin 100 mg vandfri tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
guaifenesin 600 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
aminophyllin 25 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
aminophyllin 25 mg/ml injektionsvæske, opløsning, ampul a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
aminophyllin 250 mg/10 ml injektionsvæske, ampul a 20 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin kapsel med modificeret udløsning a 300 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin kapsel med modificeret udløsning a 50 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
theophyllin 600 mg vandfri tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing zileuton (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing diprophylline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
aminophyllin tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Aminophylline-containing product in rectal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Aminophylline 250 mg rectal suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Product containing precisely aminophylline 500 milligram/1 each conventional release rectal suppository (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
Aminophylline 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some
aminophyllin 105 mg/5 ml oral væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	middel med virkning på det muskuloskeletale system	Inferred relationship	Some

Start Page 2 of 3 End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198528012	Musculoskeletal system agent (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211724014	Musculoskeletal system agent	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4629581000005112	middel med virkning på det muskuloskeletale system	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)